Literature DB >> 12584208

Gastric inhibitory polypeptide links overnutrition to obesity.

A Ballinger1.   

Abstract

Entities:  

Year:  2003        PMID： 12584208      PMCID： PMC1773560          DOI： 10.1136/gut.52.3.319

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  13 in total

1.  Identification of the intestinal cell storing gastric inhibitory peptide.

Authors:  R Buffa; J M Polak; A G Pearse; E Solcia; L Grimelius; C Capella
Journal:  Histochemistry       Date:  1975-06-05

2.  Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice.

Authors:  K Miyawaki; Y Yamada; H Yano; H Niwa; N Ban; Y Ihara; A Kubota; S Fujimoto; M Kajikawa; A Kuroe; K Tsuda; H Hashimoto; T Yamashita; T Jomori; F Tashiro; J Miyazaki; Y Seino
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  Cellular localization of gastric inhibitory polypeptide in the duodenum and jejunum.

Authors:  J M Polak; S R Bloom; M Kuzio; J C Brown; A G Pearse
Journal:  Gut       Date:  1973-04       Impact factor: 23.059

4.  Intestinal factors in the control of insulin secretion.

Authors:  N McIntyre; C D Holdsworth; D S Turner
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

5.  Further purification of a polypeptide demonstrating enterogastrone activity.

Authors:  J C Brown; V Mutt; R A Pederson
Journal:  J Physiol       Date:  1970-07       Impact factor: 5.182

Review 6.  Gastric inhibitory polypeptide: the neglected incretin revisited.

Authors:  Juris J Meier; Michael A Nauck; Wolfgang E Schmidt; Baptist Gallwitz
Journal:  Regul Pept       Date:  2002-07-15

7.  Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 [7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects.

Authors:  M A Nauck; E Bartels; C Orskov; R Ebert; W Creutzfeldt
Journal:  Digestion       Date:  1992       Impact factor: 3.216

8.  Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7-36) amide, on fatty acid synthesis in explants of rat adipose tissue.

Authors:  J Oben; L Morgan; J Fletcher; V Marks
Journal:  J Endocrinol       Date:  1991-08       Impact factor: 4.286

9.  Gastric inhibitory polypeptide enhancement of the insulin effect on fatty acid incorporation into adipose tissue in the rat.

Authors:  B Beck; J P Max
Journal:  Regul Pept       Date:  1983-09

10.  Inhibition of gastric inhibitory polypeptide signaling prevents obesity.

Authors:  Kazumasa Miyawaki; Yuichiro Yamada; Nobuhiro Ban; Yu Ihara; Katsushi Tsukiyama; Heying Zhou; Shimpei Fujimoto; Akira Oku; Kinsuke Tsuda; Shinya Toyokuni; Hiroshi Hiai; Wataru Mizunoya; Tohru Fushiki; Jens Juul Holst; Mitsuhiro Makino; Akira Tashita; Yukari Kobara; Yoshiharu Tsubamoto; Takayoshi Jinnouchi; Takahito Jomori; Yutaka Seino
Journal:  Nat Med       Date:  2002-06-17       Impact factor: 53.440
View more
  3 in total

1.  Long-term results of biliopancreatic diversion with or without gastric preservation for morbid obesity.

Authors:  Nicola Crea; Giacomo Pata; Ernesto Di Betta; Francesco Greco; Claudio Casella; Antonio Vilardi; Francesco Mittempergher
Journal:  Obes Surg       Date:  2011-02       Impact factor: 4.129

2.  Duodenal switch: long-term results.

Authors:  Picard Marceau; Simon Biron; Frédéric-Simon Hould; Stéfane Lebel; Simon Marceau; Odette Lescelleur; Laurent Biertho; Serge Simard
Journal:  Obes Surg       Date:  2007-11       Impact factor: 4.129

3.  Gastric inhibitory polypeptide receptor: association analyses for obesity of several polymorphisms in large study groups.

Authors:  Carla I G Vogel; André Scherag; Günter Brönner; Thuy T Nguyen; Hai-Jun Wang; Harald Grallert; Alexa Bornhorst; Dieter Rosskopf; Henry Völzke; Thomas Reinehr; Winfried Rief; Thomas Illig; H-Erich Wichmann; Helmut Schäfer; Johannes Hebebrand; Anke Hinney
Journal:  BMC Med Genet       Date:  2009-03-02       Impact factor: 2.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.